GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dezhan Healthcare Co Ltd (SZSE:000813) » Definitions » Price-to-Funds-From-Operations

Dezhan Healthcare Co (SZSE:000813) Price-to-Funds-From-Operations : (As of Dec. 11, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Dezhan Healthcare Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Dezhan Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
No. 235 Yin Chuan Road, Xinjiang, Urumqi, CHN, 830054
Dezhan Healthcare Co Ltd's main business is drug research and development, production, and sales. The company's wholly-owned subsidiary Jialin Pharmaceuticals mainly engages in the research and development, production, and sale of cardiovascular drugs, the drugs being produced and sold including Ale (10mg), Alle (20mg), hydrochloric acid quercetine capsules, Van Le tablets type 1, Van Le tablets.
Executives
Zhang Yong Director
Gao Li Supervisors
Sun Ji Lu Supervisors
Wang Xiao Ping Director